IDEX Corp

IEX has pivoted structurally lower in a Stage 3 corrective phase, with price confined below declining 9/20 EMAs and the 50 SMA and active bearish pivot pattern signaling medium-term downward mean reversion. Short-term conditions favor selling into rallies toward the 225–228 EMA/50 SMA zone, despite the long-term uptrend remaining intact above the 200 DMA.

• ↑Q2 2026 HST organic orders grew 47%, driving 28% overall order growth.
• ↑Achieved 26% adjusted EBITDA margin and $177M free cash flow.
• ↓Management cites fixed-cost pressures undermining margin stability.